| Code | 7352D | ||||||||||
| MA number | 44/0218/19-S | ||||||||||
| Product Form: | cps dur 30x1x25 mg (blis.Al/OPA/Al/PVC-jednotliv.dáv.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 24.07.2019 |
| PIL: |
PIL_Sunitinib Mylan 25 mg_11.2022.pdf
|
| SPC: |
SPC_Sunitinib Mylan 25 mg_05.2024.pdf
|
| Safety feature | Yes |
| Data update: | 09.05.2024 |
